E van Strijen

718 total citations
17 papers, 579 citations indexed

About

E van Strijen is a scholar working on Pharmacology, Molecular Medicine and Oncology. According to data from OpenAlex, E van Strijen has authored 17 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Molecular Medicine and 4 papers in Oncology. Recurrent topics in E van Strijen's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (8 papers) and Drug Transport and Resistance Mechanisms (2 papers). E van Strijen is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (8 papers) and Drug Transport and Resistance Mechanisms (2 papers). E van Strijen collaborates with scholars based in Netherlands and Slovenia. E van Strijen's co-authors include H. Mattie, Peter H. Nibbering, Nicolle H. R. Litjens, Herman Mattie, C. van Gulpen, Jaap T. van Dissel, Joost B. Vos, Pieter S. Hiemstra, Louise A. Duits and M L van Ogtrop and has published in prestigious journals such as Nature Communications, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

E van Strijen

17 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E van Strijen Netherlands 13 157 147 133 132 113 17 579
Katsuhisa Nakata Japan 15 204 1.3× 128 0.9× 184 1.4× 147 1.1× 147 1.3× 28 710
Neeta Datta Finland 10 236 1.5× 130 0.9× 80 0.6× 130 1.0× 80 0.7× 20 709
Herman Mattie Netherlands 12 137 0.9× 284 1.9× 107 0.8× 52 0.4× 90 0.8× 22 673
M Tanaka Japan 13 228 1.5× 49 0.3× 200 1.5× 186 1.4× 188 1.7× 23 689
Yuanyuan Dai China 17 376 2.4× 76 0.5× 68 0.5× 81 0.6× 116 1.0× 86 887
Marie-Thérèse Labro France 12 88 0.6× 133 0.9× 139 1.0× 65 0.5× 115 1.0× 20 512
Kenji Namba Japan 10 161 1.0× 69 0.5× 70 0.5× 136 1.0× 105 0.9× 18 446
Hany I. Kenawy Egypt 13 146 0.9× 169 1.1× 46 0.3× 39 0.3× 181 1.6× 22 574
Martina Bosnar Croatia 17 222 1.4× 202 1.4× 120 0.9× 42 0.3× 199 1.8× 39 912
Xingzhen Lao China 15 592 3.8× 87 0.6× 80 0.6× 129 1.0× 144 1.3× 32 957

Countries citing papers authored by E van Strijen

Since Specialization
Citations

This map shows the geographic impact of E van Strijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E van Strijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E van Strijen more than expected).

Fields of papers citing papers by E van Strijen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E van Strijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E van Strijen. The network helps show where E van Strijen may publish in the future.

Co-authorship network of co-authors of E van Strijen

This figure shows the co-authorship network connecting the top 25 collaborators of E van Strijen. A scholar is included among the top collaborators of E van Strijen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E van Strijen. E van Strijen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Korbee, Cornelis J., Dragi Kocev, E van Strijen, et al.. (2018). Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials. Nature Communications. 9(1). 358–358. 45 indexed citations
2.
Broek, P.J. van den, et al.. (2009). Endemic and Epidemic Acinetobacter Species in a University Hospital: an 8-Year Survey. Journal of Clinical Microbiology. 47(11). 3593–3599. 60 indexed citations
3.
Litjens, Nicolle H. R., Jacobus Burggraaf, E van Strijen, et al.. (2004). Pharmacokinetics of oral fumarates in healthy subjects. British Journal of Clinical Pharmacology. 58(4). 429–432. 119 indexed citations
4.
Litjens, Nicolle H. R., E van Strijen, C. van Gulpen, et al.. (2004). In vitro pharmacokinetics of anti-psoriatic fumaric acid esters. BMC Pharmacology. 4(1). 22–22. 55 indexed citations
5.
Duits, Louise A., et al.. (2003). Rhinovirus increases human β-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunology & Medical Microbiology. 38(1). 59–64. 102 indexed citations
6.
Broek, P.J. van den, et al.. (1999). Intracellular activity of trovafloxacin against Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 44(2). 193–199. 11 indexed citations
7.
Mattie, H., et al.. (1997). Pharmacokinetic and pharmacodynamic models of the antistaphylococcal effects of meropenem and cloxacillin in vitro and in experimental infection. Antimicrobial Agents and Chemotherapy. 41(10). 2083–2088. 19 indexed citations
8.
Mattie, H., et al.. (1994). The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.. British Journal of Clinical Pharmacology. 37(2). 193–197. 29 indexed citations
9.
Mattie, H., et al.. (1993). The passage of cloxacillin into cerebrospinal fluid in the absence of meningitis.. British Journal of Clinical Pharmacology. 36(1). 57–60. 15 indexed citations
10.
Mattie, H., et al.. (1992). Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 36(11). 2439–2443. 16 indexed citations
11.
Mattie, H., et al.. (1992). Diffusion of cloxacillin into synovial tissue.. British Journal of Clinical Pharmacology. 34(3). 275–277. 5 indexed citations
12.
Ogtrop, M L van, et al.. (1992). Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice. Antimicrobial Agents and Chemotherapy. 36(11). 2375–2380. 18 indexed citations
13.
Ogtrop, M L van, et al.. (1991). Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 35(3). 417–422. 3 indexed citations
14.
Ogtrop, M L van, et al.. (1991). Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam. Antimicrobial Agents and Chemotherapy. 35(5). 983–985. 5 indexed citations
15.
Mattie, H., et al.. (1990). AntibactERial Activity of Four Cephalosporins in an ExpERimental Infection in Relation to In Vitro Effect and Pharmacokinetics. The Journal of Infectious Diseases. 162(3). 717–722. 23 indexed citations
16.
Ogtrop, M L van, et al.. (1990). Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 34(10). 1932–1937. 31 indexed citations
17.
Bruijn, E. A. de, O. Driessen, E van Strijen, et al.. (1983). A gas chromatographic assay for the determination of 5,6-dihydrofluorouracil and 5-fluorouracil in human plasma. PubMed. 278(2). 283–289. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuhisa Nakata Breakdown of academic impact, for papers by Neeta Datta Breakdown of academic impact, for papers by Herman Mattie Breakdown of academic impact, for papers by M Tanaka Breakdown of academic impact, for papers by Yuanyuan Dai Breakdown of academic impact, for papers by Marie-Thérèse Labro Breakdown of academic impact, for papers by Kenji Namba Breakdown of academic impact, for papers by Hany I. Kenawy Breakdown of academic impact, for papers by Martina Bosnar Breakdown of academic impact, for papers by Xingzhen Lao
Rankless by CCL
2026